Integra Therapeutics secures €10.7 million investment round to advance development of FiCAT gene writing platform and preclinical validation of CAR-T therapies

Integra Therapeutics, a global leader in cutting-edge gene writing tools to improve the efficacy, precision and safety of advanced therapies, announced it has closed a €10.7 million pre Series A round of investment. The funds come from new investors like the EIC Fund —the venture capital arm of the European Innovation Council (EIC) with the […]